Transdermal drug delivery: The inherent challenges and technological advancements

Asian Journal of Pharmaceutical Sciences

Volumn 5, Issue 6, 2010, Pages 276-288

  Ahad, A ^a   Aqil, M ^a   Kohli, K ^a   Sultana, Y ^a   Mujeeb, M ^a   Ali, A ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Electroporation; Iontophoresis; Microneedle; Penetration enhancer; Sonophoresis; Transdermal

Indexed keywords

ARTICLE; ELECTROPORATION; IONTOPHORESIS; RADIOFREQUENCY; SKIN PENETRATION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; ULTRASOUND;

EID: 78751511679     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Y. W. Chien. Transdermal drug delivery and delivery systems, in: Y.W. Chien (Ed), Novel Drug Delivery Systems, 2nd ed., Chapter 7, Marcel Dekker, New York, 1992, 301-380.
2. M. R. Prausnitz, S. Mitragotri, R. Langer. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov., 2004, 3: 115-124.
3. M. Aqil, Y. Sultana, A. Ali. Transdermal delivery of β-blockers. Expert opinion., 2006, 3: 405-418.
4. B. J. Thomas, B. C. Finnin. The transdermal revolution. Drug Disc. Today, 2004, 9: 697-703.
5. B. C. Finnin, T. M. Morgan. Transdermal penetration enhancers: applications, limitations, and potential. J. Pharm. Sci., 1999, 88: 955-958.
6. R. H. Guy. Current status and future prospects of transdermal drug delivery. Pharm. Res., 1996, 13: 1765-1769.
7. B. W. Barry. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci., 2001, 14: 101-114.
8. T. I. Degim. New tools and approaches for predicting skin permeability. Drug Disc. Today, 2006, 11: 517-523.
9. M. Aqil, A. Ahad, Y. Sultana, et al. Status of terpenes as skin penetration enhancers. Drug Disc. Today, 2007, 12: 1061-1067.
10. R. H. Bogner, M. F. Wilkos. Transdermal drug delivery part 2: upcoming developments. U.S. Pharmacist., 2005, 28: 8-10.
11. G. Cevc. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev., 2004, 56: 675-711.
12. V. Preat, R. Vanbever. Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev., 2004, 56: 659-674.
13. A. Doukas. Transdermal delivery with a pressure wave. Adv. Drug Deliv. Rev., 2004, 56: 559-579.
14. S. Mitragotri, J. Kost. Low-frequency sonophoresis: a review. Adv. Drug Deliv. Rev., 2004, 56: 589-601.
15. L. Ilana, K. Joseph. Ultrasound and transdermal drug delivery. Drug. Disc. Today., 2004, 9: 670-676.
16. S. Leduc. Electric ions and their use in medicine. Rebman Ltd., Liverpool, UK (1908).
17. J. Singh, M. Gross, B. Sage, et al. Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. Food Chem. Toxicol., 2001, 39: 1079-1086.
18. M. K. Kim, N. M. Kini, T. J. Troshynski, et al. A randomized clinical trial of dermal anesthesia by iontophoresis for peripheral intravenous catheter placement in children. Ann. Emerg. Med., 1999, 33: 395-399.
19. E. Holzle, N. Albert. Long-term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosisthe usefulness of home therapy. Dermatologica., 1987, 175: 126-135.
20. B. Berner, S. M. Dinh. Electronically assisted drug delivery: an overview. In: B. Berner, S. M. Dinh, eds. Electronically controlled drug delivery. Boca Raton, FL: CRC Press 1998: 3-7.
21. L. Le, J. Kost, S. Mitragotri. Combined effect of lowfrequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm. Res., 2000, 17: 1151-1154.
22. S. Mitragotri, D. Ray, J. Farrell, et al. Synergistic effect of ultrasound and sodium lauryl sulfate on transdermal drug delivery. J. Pharm. Sci., 2000a, 89: 892-900.
23. Y. M. Wang, L.V. Allen, L. C. Li. Effect of sodium dodecyl sulphate on iontophoresis of hydrocortisone across hairless mouse skin. Pharm. Dev. Tech., 2000, 5: 533-542.
24. M. Al-Khalili V. M. Meidan, B. B. Michniak. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS Pharm. Sci., 2003, 5: 1-11.
25. S. Chesnoy, D. Durand, J. Doucet, et al. Structural parameters involved in the permeation of propranolol HCl by iontophoresis and enhancers. J. Control. Release, 1999, 58: 163-175.
26. N. Kanikkannan, J. Singh, P. Ramarao. Transdermal iontophoretic delivery of timolol maleate in albino rabbits. Int. J. Pharm., 2000, 197: 69-76.
27. G. Stagni, D. O'Donnell, Y. J. Liu, et al. Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis. J. Control. Release, 2000, 63: 331-339.
28. O. Pillai, R. Panchagnula. Transdermal iontophoresis of insulin: V. Effect of terpenes. J. Control. Release, 2003, 88: 287-296.
29. O. Pillai, S. D. Borkute, N. Sivaprasad, et al. Transdermal iontophoresis of insulin: II. Physicochemical considerations. Int. J. Pharm., 2003, 254: 271-280.
30. S. L. Chang, G. A. Hofmann, L. Zhang, et al. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Release, 2000, 66: 127-133.
31. S. Bose, W. R. Ravis, Y. J. Lin, et al. Electrically assisted transdermal delivery of buprenorphine. J. Control. Release, 2001, 73: 197-203.
32. J. Y. Fang, K. C. Sung, H. H. Lin, et al. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int. J. Pharm., 1999, 178: 83-92.
33. E. Varghese, R. K. Khar. Enhanced skin permeation of diclofenac by iontophoresis: in vitro and in vivo studies. J. Control. Release, 1996, 38: 21-27.
34. D. F. Hager, M. J. Laubach, J. W. Sharkey, et al. In vitro iontophoretic delivery of CQA 206-291: influence of ethanol. J. Control. Release, 1993, 23: 175-182.
35. A. Jadoul, J. Mesens, W. Caers, et al. Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm. Res., 1996, 13: 1348-1353.
36. L. P. Gangarosa, A. Ozawa, M. Ohkido, et al. Iontophoresis for enhancing penetration of dermatologic and antiviral drugs. J. Dermatol., 1995, 22: 865-875.
37. B. K. Chang, T. H. Guthrie, K. Hayakawa, et al. A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin. Arch. Dermatol., 1993, 129: 425-427.
38. A. Jadoul, V. Preat. Electrically enhanced transdermal delivery of domperidone, Int. J. Pharm., 1997, 154: 229-234.
39. S. Y. Oh, S. Y. Jeong, T. G. Park, et al. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J. Control. Release, 1998, 51: 161-168.
40. P.W. Ledger. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Del. Rev., 1992, 9: 289-307.
41. N. A. Charoo, Z. Rahman, M. A. Repka, et al. Electroporation: an avenue for transdermal drug delivery. Curr. Drug Deliv., 2010, 7: 125-136.
42. M. R. Prausnitz. A practical assessment of transdermal drug delivery by skin electroporation. Adv. Drug Del. Rev., 1999, 35, 61-76.
43. U. Pliquett, J. C. Weaver. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties. Bioelectrochem. Bioenerg., 1996, 39: 1-12.
44. R. Vanbever, E. LeBoulenge, V. Preat. Transdermal delivery of fentanyl by electroporation: I. influence of electrical factors. Pharm. Res., 1996,13: 559-565.
45. A. R. Denet, V. Preat. Transdermal delivery of timolol by electroporation through human skin. J. Control. Release, 2003, 88: 253-262.
46. R. Vanbever, V. Preat. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J. Control. Release, 1998, 50: 225-235.
47. T. Cheng, R. Langer, J. C. Weaver. Charged microbeads are not transported across the human stratum corneum in vitro by short high-voltage pulses. Bioelectrochem. Bioenerg., 1999, 48: 181-192.
48. C. A. Rowland, R. P. Chilcott. The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro. J. Control. Release, 2000, 68: 157-166.
49. L. Mir, S. Orlowski. Mechanisms of electrochemotherapy. Adv. Drug Deliv. Rev., 1999, 35: 107-118.
50. R. Heller, R. Gilbert, M. J. Jaroszeski. Clinical applications of electrochemotherapy. Adv. Drug Deliv. Rev., 1999, 35: 119-129.
51. R. Rastogi, S. Anand, V. Koul. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin. Drug Dev. Ind. Pharm., 2010, 36: 1303-1311.
52. S. Wang, M. Kara, T. R. Krishnan. Transdermal delivery of cyclosporin-A using electroporation. J. Control. Release, 1998, 50: 61-70.
53. R. Vanbever, M. R. Prausnitz, V. Preat. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm. Res., 1997, 14: 638-644.
54. S. E. Cross, M. S. Roberts. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development. Current Drug Deliv., 2004, 1: 81-92.
55. S. Mitragotri, J. Kost. Low frequency sonophoresis: a noninvasive method of drug delivery and diagnostics. Biotech. Prog., 2000 C, 16: 488-492.
56. R. Rao, S. Nanda. Sonophoresis: recent advancements and future trends. J. Pharm. Pharmacol., 2009, 61: 689-705.
57. J. Wu, J. Chappelow, J. Yang, et al. Defects generated in human stratum corneum specimens by ultrasound. Ultrasound. Med. Biol., 1998, 24: 705-710.
58. A. Tezel, S. Mitragotri. Interactions of inertial cavitation collapses with stratum corneum lipid bilayers. Biophys. J., 2003, 85: 1-11.
59. R. Alvarez-Roman, G. Merriono, Y. N. Kalia, et al. Skin permeability enhancement by low-frequency sonophoresis lipid extraction and transport pathways. J. Pharm. Sci., 2003, 92: 1138-1146.
60. A. Joshi, J. Raje. Sonicated transdermal drug transport. J. Control. Release, 2002, 83: 13-22.
61. A. Tezel, A. Sens, S. Mitragotri. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci., 2002, 91: 444-453.
62. A. Boucaud, M. A. Garrigue, L. Machet, et al. Effect of sonication parameters on transdemral delivery of insulin to hairless rats. J. Pharm. Sci., 2002, 91: 113-119.
63. K. Tachibana, S. Tachibana. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol., 1991, 43: 270-271.
64. K. Tachibana. Transdermal delivery of insulin to alloxandiabetc rabbits by ultrasound exposure. Pharm. Res., 1992, 9: 952-954.
65. S. Mitragotri, D. Blankschtein, R. Langer. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res., 1996, 13: 411-420.
66. A. R. Williams. Phonophoresis: an in vivo evaluation using three topical anaesthetic preparations. Ultrasonics., 1990, 28: 137-141.
67. J. Liu, T. N. Lewis, M. R. Prausnitz. Non-invasive assessment and control of ultrasound-induced membrane permeabilization. Pharm. Res., 1998, 15: 918-923.
68. H. Chuang, E. Taylor, T. W. Davison. Proceedings of the Diabetes technology meeting held on Nov. 8-9, 2000, San Francisco L.A.
69. J. H. Park, S. O. Choi, S. Seo, et al. A microneedle roller for transdermal drug delivery. Eur. J. Pharm. Biopharm., 2010, 76: 282-289.
70. R. Wang, D. L Doolan, T. P. Le. Induction of antigenspecific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science., 1998, 282: 467-480.
71. S. Henry, D. McAllister, M. G. Allen, et al. Microfabricated microneedles: a novel method to increase transdermal drug delivery. J. Pharm. Sci., 1987, 87: 922-925.
72. W. Martanto, S. Davis, N. Holiday, et al. Transdermal delivery of insulin using microneedles in vivo, proceedings of international symposium on controlled release bioactive material, No. 666, 2003.
73. D. V. McAllister, P. M. Wang, S. P. Davis, et al. Prausnitz. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Nat. Acad. Sci. (USA), 2003, 100: 13755-13760.
74. A. C. Sintov, I. Krymberk, D. Daniel, et al. Radiofrequency driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Release, 2003, 89: 311-320.
75. J. H. Park, J. W. Lee, Y. C. Kim, et al. The effect of heat on skin permeability. Int. J. Pharm., 2008; 359: 94-103.
76. Y. Liu, M. A. Kendall. Optimization of a jet-propelled particle injection system for the uniform transdermal delivery of drug/vaccine. Biotechnol Bioeng., 2007, 97: 1300-1308.
77. J. Schramm, S. Mitragotri. A fundamental investigation of drug delivery using jet injectors: energetics of jet formation and penetration. Pharm. Res., 2002, 19: 1673-1679.
78. H. J. Dean, D. Fuller, J. E. Osorio. Powder and particlemediated approaches for delivery of DNA and protein vaccines into the epidermis. Comp. Immunol. Microbiol. Infect. Dis., 2003, 26: 373-388.
79. J. Bennett, F. Nichols, M. Rosenblum, et al. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle. J. Oral Maxillofac. Surg., 1998, 56: 1249-1254.
80. M. A. Pellett, S. L. Raghavan, J. Hadgraft, et al. The application of supersaturated systems to percutaneous drug delivery; in: R. H. Guy, J. Hadgraft (Eds.), Transdermal Drug Delivery., Vol. 123, Marcel Dekker, New York, 2003: 305-326.
81. M. F. Coldman, B. J. Poulsen, T. Higuchi. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J. Pharm. Sci., 1969, 58: 1098-1102.
82. K. Moser, K. Kriwet, Y. N. Kalia, et al. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J. Control. Release, 2001, 73: 245-253.
83. A. F. Davis, J. Hadgraft. Effect of supersaturation on membrane transport. Hydrocortisone acetate. Int. J. Pharm., 1991, 76: 1-8.
84. K. Moser, K. Kriwet, C. Froehlich, et al. Permeation enhancement of a highly lipophilic drug using supersaturated systems. J. Pharm. Sci., 2001, 90: 605-614.
85. S. Kondo, D. Yamanaka, I. Sugimoto. Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. J. Pharmacobio-Dyn., 1987, 10: 743-749.
86. S. Lee, N. Kollias, D. J. McAuliffe, et al. Topical drug delivery in humans with a single photomechanical wave. Pharm. Res., 1999, 16: 1717-1721.
87. G. K. Menon, P. M. Elias. Morphologic basis for a porepathway in mammalian stratum corneum. Skin Pharmacol., 1997, 10: 235-246.
88. S. Lee, D. J. McAuliffe, S. E. Mulholland, et al. Photomechanical transdermal delivery of insulin in vivo. Lasers Surg. Med., 2001, 28: 282-285.
89. M. Terakawa, H. Tsuda, H. Ashida, et al. Assessment of tissue alteration in skin after interaction with photomechanical waves used for gene transfection. Lasers Surg Med., 2010, 42: 400-407.
90. V. P. Shah, C. C. Peck, R. L. Williams, in: Walters KA, Hadgraft J (Eds.), pharmaceutical skin penetration enhancement, Marcel Dekker, New York, 1993, 417-427.
91. A. C. Williams, B.W. Barry. Penetration enhancers. Adv. Drug Del. Rev., 2004, 56: 603-618.
92. J. Y. Fang, C. F. Hung, Y. P. Fang, et al. Transdermal Iontophoresis of 5-fluorouracll combined with electroporation and laser treatment. Int. J. Pharm., 2004, 270: 241-249.
93. J. E. Riviere, A. Nancy, M. Riviere, et al. Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and toxicology. J. Control. Release, 1995, 36: 229-233.
94. J. Y. Fang, H. H. Lin, H. I. Chen, et al. Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis. J. Control. Release, 1998, 54: 293-304.
95. A. R. Denet, B. Ucakar, V. Preat. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach. Pharm. Res., 2003, 20: 1946-1951.
96. A. V. Badkar, A. K. Banga. Electrically enhanced transdermal delivery of a macromolecule. J. Pharm. Pharmacol., 2002, 54: 907-912.
97. H. Y. Zhao, J. M. Zheng, Y. Pan, et al. Effect of electroporation and iontophoresis on skin permeation of Defibrase® a purified thrombin-like enzyme from the venon of Agkistrodon halys ussuriensis Emelianov. Pharmazie., 2002, 57: 482-484.
98. A. Doliwa, S. Santoyo, P. Ygartua. Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam. Int. J. Pharm., 2001, 229: 37-44.
99. S. Ganga, P. Ramarao, J. Singh. Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. J. Control. Release, 1996, 42: 57-64.
100. A. Banga, S. Bose, T. Ghosh. Iontophoresis and electroporation: comparisons and contrasts. Int. J. Pharm., 1999, 179: 1-19.
101. S. Mitragotri. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res., 2000, 17: 1354-1359.
102. T. E. Zewert, U. F. Pliquett, R. Vanbever, et al. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule. Bioelectrochem. Bioenerg., 1999, 49: 11-20.
103. D. Monti, R. Gainnelli, P. Chetoni, et al. Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro. Int. J. Pharm., 2001, 229: 131-137.
104. J. Kost, U. Pliquett, S. Mitragotri, et al. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm. Res., 1996, 13: 633-638.
105. G. A. Hofmann, W. V. Rustrum, K. S. Suder. Electroincorporation of microcarriers as a method for the transdermal delivery of large molecules. Bioelectrochem. Bioenerg., 1995, 38: 209-222.
106. M. R. Prausnitz, E. R. Edelman, J. A. Gimm, et al. Weaver. transdermal delivery of heparin by skin electroporation. Biotechnology., 1995, 13: 1205-1209.
107. T. E. Zewert, U. F. Pliquett, R. Langer, et al. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Res. Commun., 1995, 212: 286-292.
108. L. Zhang, L. Li, G. A. Hofmann, et al. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin ageing and other diseases. Biochem. Biophys. Res. Commun., 1996, 220: 633-636.
109. A. Mishra, S. Ganga, P. Upadhyay. Needle-free, nonadjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine., 1999, 18: 517-523.
110. A. Sen, M. E. Daly, S. W. Hui. Transdermal insulin delivery using lipid enhanced electroporation. Biochim. Biophys. Acta., 2002, 1564: 5-8.
111. M. B. Brown, G. P. Martin, S. A. Jones, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv., 2006, 13: 175-187.
112. J. Kost, S. Mitragotri, R. Gabbuy, et al. Transdermal monitoring of glucose and other analytes using ultrasound. Nat. Med., 2000, 6: 347-350.
113. J. T. Santini, M. J. Cima, R. Langer. A controlled-release microchip. Nature, 1999, 397: 335-338.
114. R. Langer. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res., 2000, 33: 94-101.